
    
      A Phase 3 Prospective, Randomized, Multicenter, Open Label, Central Assessor Blinded,
      Parallel Group, Comparative Study To Determine The Efficacy, Safety And Tolerability Of
      Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem±Colistin (MER±COL) For
      The Treatment Of Serious Infections Due To Gram Negative Bacteria, Including Metallo Β
      Lactamase (MBL) - Producing Multidrug Resistant Pathogens, For Which There Are Limited Or No
      Treatment Options
    
  